Frank Rhame, MD
Basic profileFrank Rhame is an Infectious Disease physician affiliated with University of Minnesota. OpenAlex indexes 150 publications with 5,291 citations (h-index 40); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Raltegravir Kaletra Pharmacokinetics
Sponsor: Allina Health System
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- DiaSorin Inc.Program year20241 payment$1,925
- JanssenProgram year202311 paymentsResearch$384,261
- DiaSorinProgram year20231 paymentResearch$9,500
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
30.8%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor15.6%Dovato41%Tivicay34%Juluca15%Isentress7%Isentress Hd3%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor7%Descovy68%Triumeq20%Abacavir-Lamivudine6%Abacavir6%Part D<11 patients+ 9 more classes in this area
Nervous system
28.3%Opioid Agonist7.5%Oxycodone-Acetaminophen35%Tramadol Hcl23%Oxycodone Hcl21%Morphine Sulfate Er15%Fentanyl6%Part D<11 patientsBenzodiazepine7.1%Alprazolam32%Diazepam25%Lorazepam25%Temazepam12%Clonazepam6%Part D<11 patients+ 8 more classes in this area
Cardiovascular
20.3%Statin7.2%Atorvastatin Calcium68%Rosuvastatin Calcium24%Lovastatin8%Part D<11 patientsThiazide diuretic3.4%Hydrochlorothiazide100%Part D≥14 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Jay Cohn, MD
University of Minnesota
Carol Bradford, MD
University of Minnesota
Douglas Yee, MD
University of Minnesota
David Benditt, MD
University of Minnesota
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”